Cardiff Oncology, Inc. (CRDF) Earnings Call Transcripts
About Cardiff Oncology, Inc.
Cardiff Oncology, Inc. (CRDF) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 18 calls on record spanning September 23, 2020 to June 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 18 Cardiff Oncology, Inc. earnings call transcripts on record, spanning September 23, 2020 to June 3, 2026. Based on this history, Cardiff Oncology, Inc. reports semi-annually. The most recent call on file is dated June 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- CRDF
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 18
- First call
- September 23, 2020
- Most recent
- June 3, 2026
- Reporting cadence
- semi-annually
| Quarter | Date | |
|---|---|---|
| Special Calls | Jun 3, 2026 | Read transcript → |
| Special Calls | Mar 25, 2026 | Read transcript → |
| Special Calls | Jan 27, 2026 | Read transcript → |
| Special Calls | Jul 29, 2025 | Read transcript → |
| Q4 FY2024 | Feb 27, 2025 | Read transcript → |
| Special Calls | Dec 10, 2024 | Read transcript → |
| Q2 FY2024 | Aug 8, 2024 | Read transcript → |
| Q1 FY2024 | May 2, 2024 | Read transcript → |
| Q4 FY2023 | Feb 29, 2024 | Read transcript → |
| Q3 FY2023 | Nov 2, 2023 | Read transcript → |
| Special Calls | Sep 26, 2023 | Read transcript → |
| Special Calls | Aug 7, 2023 | Read transcript → |
| Company Conference Presentations | Jan 18, 2023 | Read transcript → |
| Special Calls | Sep 12, 2022 | Read transcript → |
| Special Calls | Jan 18, 2022 | Read transcript → |
| Special Calls | Sep 8, 2021 | Read transcript → |
| Special Calls | Apr 12, 2021 | Read transcript → |
| Special Calls | Sep 23, 2020 | Read transcript → |